Acrobiosystems Co.,Ltd.

¥87.12As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301080Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR 3.27%
Div yield 0.69%
ROE 7.24%
Biotechnology
Beta (5Y) 0.89
PE TTM 74.90
TSR TTM 36.69%
Mkt cap ¥14.61B
ROIC 10.26%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥98
13.05%
179.84%
Hold 12|5|5|3|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.44
1.39
1.42
1.57
14.97%
0.47%
2.85%
7.75%
Revenue¥M
631.1
625.0
658.8
689.7
1.57%
0.21%
8.29%
8.89%
Peers (US$2.190B)
Cap (US$)
PE
2.112B
90.48x
2.187B
—
Capital
TTM
5Y
10Y
Leveragex
1.080
(0.119)
(0.094)
EBIT/Intx
1.997
0.768
0.831
Own earn%
(93.45)
(32.46)
(30.01)
Sh yield%
26.11
42.55
45.50
Owners
Insiders/Inst%
3.87
65.10
Short interest%
1.47
SBC / revenue%
4.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
0–4
$1 testx
0.0
Incr. ROIC%
5